MiR-718 represses VEGF and inhibits ovarian cancer cell progression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-718 represses VEGF and inhibits ovarian cancer cell progression
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 588, Issue 12, Pages 2078-2086
Publisher
Wiley
Online
2014-05-09
DOI
10.1016/j.febslet.2014.04.040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
- (2013) S Carbajo-Pescador et al. BRITISH JOURNAL OF CANCER
- The Effect of VEGF-Targeted Therapy on Biomarker Expression in Sequential Tissue from Patients with Metastatic Clear Cell Renal Cancer
- (2013) K. Sharpe et al. CLINICAL CANCER RESEARCH
- High circulating VEGF level predicts poor overall survival in lung cancer
- (2013) Pingping Hu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Triptolide Induces Apoptosis and Inhibits the Growth and Angiogenesis of Human Pancreatic Cancer Cells by Downregulating COX-2 and VEGF
- (2013) Jian-Xia Ma et al. ONCOLOGY RESEARCH
- Prospective Validation of Candidate SNPs of VEGF/VEGFR Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab
- (2013) Fotios Loupakis et al. PLoS One
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
- (2012) A. R. M. van der Bilt et al. CLINICAL CANCER RESEARCH
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
- (2012) Cheng-Xiong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- VEGF Antibody Plus Cisplatin Reduces Angiogenesis and Tumor Growth in a Xenograft Model of Ovarian Cancer
- (2012) Putul Maity et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF
- (2012) Qian Bi et al. PLoS One
- VEGF-C as a Decision-making Biomarker for Selected Patients with Invasive Bladder Cancer Who Underwent Bladder-preserving Radical Surgery
- (2011) Zhuo Li et al. ARCHIVES OF MEDICAL RESEARCH
- Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer
- (2011) Ying Kong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells
- (2010) X. Fan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MiR-125b targets BCL3 and suppresses ovarian cancer proliferation
- (2010) Yi Guan et al. INTERNATIONAL JOURNAL OF CANCER
- HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase
- (2010) K. Selvendiran et al. MOLECULAR CANCER RESEARCH
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
- (2009) R. Bhattacharya et al. CANCER RESEARCH
- MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
- (2009) Bo Liu et al. LUNG CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids
- (2008) Haitao Luo et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now